Single User License
INR 161050
Site License
INR 322100
Corporate User License
INR 483150

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015

Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2588CTIDB
  • |
  • Pages: 80
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Myxoid Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myxoid Liposarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myxoid Liposarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Myxoid Liposarcoma 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Middle East and Africa 12

Top Countries Contributing to Clinical Trials in Central and South America 13

Clinical Trials by G7 Countries: Proportion of Myxoid Liposarcoma to Oncology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Myxoid Liposarcoma to Oncology Clinical Trials 17

Clinical Trials by Phase in E7 Countries 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Clinical Trials by End Point Status 22

Subjects Recruited Over a Period of Time 23

Clinical Trials by Sponsor Type 24

Prominent Sponsors 25

Top Companies Participating in Myxoid Liposarcoma Therapeutics Clinical Trials 26

Prominent Drugs 27

Clinical Trial Profiles 28

Clinical Trial Overview of Top Companies 28

Johnson & Johnson 28

Clinical Trial Overview of Johnson & Johnson 28

F. Hoffmann-La Roche Ltd. 29

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 29

Eisai Co., Ltd. 30

Clinical Trial Overview of Eisai Co., Ltd. 30

CTI BioPharma Corp. 31

Clinical Trial Overview of CTI BioPharma Corp. 31

Clinical Trial Overview of Top Institutes / Government 32

Fred Hutchinson Cancer Research Center 32

Clinical Trial Overview of Fred Hutchinson Cancer Research Center 32

Leiden University Medical Center 33

Clinical Trial Overview of Leiden University Medical Center 33

Vector Oncology 34

Clinical Trial Overview of Vector Oncology 34

The Alliance for Clinical Trials in Oncology 35

Clinical Trial Overview of The Alliance for Clinical Trials in Oncology 35

Fondazione IRCCS-Istituto Nazionale dei Tumori 36

Clinical Trial Overview of Fondazione IRCCS-Istituto Nazionale dei Tumori 36

Grupo Espanol de Investigacion en Sarcomas 37

Clinical Trial Overview of Grupo Espanol de Investigacion en Sarcomas 37

Istituto Nazionale per lo Studio e la Cura dei Tumori 38

Clinical Trial Overview of Istituto Nazionale per lo Studio e la Cura dei Tumori 38

European Organization for Research and Treatment of Cancer 39

Clinical Trial Overview of European Organization for Research and Treatment of Cancer 39

Five Key Clinical Profiles 40

Appendix 77

Abbreviations 77

Definitions 77

Research Methodology 78

Secondary Research 78

About GlobalData 79

Contact Us 79

Disclaimer 79

Source 80

List of Figures

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Myxoid Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 9

Myxoid Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10

Myxoid Liposarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11

Myxoid Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 12

Myxoid Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 13

Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14

Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 17

Myxoid Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23

Myxoid Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24

Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25

Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26

Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

GlobalData Methodology 78

List of Tables

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Region, 2015* 6

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Myxoid Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 9

Myxoid Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10

Myxoid Liposarcoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Myxoid Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12

Myxoid Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13

Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14

Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 17

Myxoid Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Phase, 2015* 19

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20

Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Myxoid Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22

Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23

Myxoid Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24

Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25

Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26

Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 28

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 29

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 30

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by CTI BioPharma Corp., 2015* 31

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 32

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 33

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Vector Oncology, 2015* 34

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Alliance for Clinical Trials in Oncology, 2015* 35

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione IRCCS-Istituto Nazionale dei Tumori, 2015* 36

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Grupo Espanol de Investigacion en Sarcomas, 2015* 37

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Nazionale per lo Studio e la Cura dei Tumori, 2015* 38

Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Myxoid Liposarcoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Myxoid Liposarcoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com